Keeping Track: US FDA, Industry Roar Into Fourth Quarter With Bevy Of Regulatory Announcements
The latest drug development news and highlights from our US FDA Performance Tracker.
You may also be interested in...
Likelihood of webcast-only advisory committee meetings may depend on the extent of the coronavirus outbreak, Office of New Drugs Director Peter Stein tells the Pink Sheet in an interview.
Productivity may suffer under coronavirus-mandated telework despite workforce diligence, experts say.
Sponsors have been asked to switch to teleconferences with FDA staff as the agency prepares for more of its employees to work from home.